Sfoglia per Autore
The mechanisms of resistance to EGFR inhibitors.
2007 Bianco, Roberto; Gelardi, Teresa; Damiano, Vincenzo; Tortora, Giampaolo
Combination of biological therapies in non-small cell lung cancer.
2006 Bianco, Roberto; Damiano, Vincenzo; Tortora, Giampaolo
Novel TLR9 agonist induces EGFR inhibition and synergistic antitumor activity with EGFR inhibitors.
2006 Damiano, Vincenzo; Caputo, R; Bianco, Roberto; D'Armiento, FRANCESCO PAOLO; Leonardi, Antonio; DE PLACIDO, Sabino; Bianco, Ar; Agrawal, S; Ciardiello, F; Tortora, Giampaolo
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients.
2005 De Vita, F; Orditura, M; Matano, E; Bianco, Roberto; Carlomagno, Chiara; Infusino, S; Damiano, Vincenzo; Simeone, E; Diadema, Mr; Lieto, E; Castellano, P; Pepe, S; DE PLACIDO, Sabino; Galizia, G; Di Martino, N; Ciardiello, F; Catalano, G; Bianco, A. R.
Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer.
2005 Melisi, Davide; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Veneziani, BIANCA MARIA; Bianco, Ar; DE PLACIDO, Sabino; Ciardiello, F; Tortora, Giampaolo
Therapeutic integration of signal transduction targeting agents and conventional anti-cancer treatments.
2004 Melisi, Davide; Troiani, T; Damiano, Vincenzo; Tortora, Giampaolo; Ciardiello, F.
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy.
2004 Ciardiello, F; Bianco, Roberto; Caputo, R; Caputo, R; Damiano, Vincenzo; Troiani, T; Melisi, D; DE VITA, F; DE PLACIDO, Sabino; Bianco, Ar; Tortora, G.
A phase II study of beweekly oxaliplatin plus infusional 5fluorouracil and folinic acid (FOLFOX4) as first-line treatment of advenced gastric cancer patients
2004 F., De Vita; M., Orditura; Matano, Elide; Bianco, Roberto; Carlomagno, Chiara; S., Infusino; Damiano, Vincenzo; E., Simeone; Mr, Diadema; E., Lieto; P., Castellano; S., Pepe; DE PLACIDO, Sabino; G., Galizia; F., Ciardiello; G., Catalano; Ar, Bianco
Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model.
2004 Raben, D; Bianco, C; Damiano, Vincenzo; Bianco, Roberto; Melisi, Davide; Mignogna, C; D'Armiento, FRANCESCO PAOLO; Cionini, L; Bianco, Ar; Tortora, Giampaolo; Ciardiello, F; Bunn, P.
Combined targeted inhibition of Bcl-2, Bcl-xL, EGFR and Protein Kinase A Type I causes potent antitumor, apoptotic and antiangiogenic activity
2003 Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Caputo, R; Troiani, T; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Ar; ZANGEMEISTER WITTKE, U; Ciardiello, F.
Antitumor effects of ZD6474, a small molecule Vascular Endothelial Growth Factor receptor tyrosine kinase inhibitor, with additional activity against Epidermal Growth Factor.
2003 Ciardiello, F; Caputo, R; Damiano, Vincenzo; Caputo, R; Troiani, T; Vitagliano, D; Carlomagno, F; Veneziani, BIANCA MARIA; Fontanini, G; Bianco, Ar; Tortora, Giampaolo
Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective EGFR-tyrosine kinase inhibitor ZD1839 (‘Iressa’)
2002 Bianco, C; Tortora, Giampaolo; Bianco, Roberto; Caputo, R; Veneziani, BIANCA MARIA; Caputo, R; Damiano, Vincenzo; Troiani, T; Fontanini, G; Raben, D; Pepe, Stefano; Bianco, Ar
Inhibition of growth factors production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.
2001 Ciardiello, F; Caputo, R; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; Cuccato, S; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo
Oral administration of a novel taxane, an antisense oligonucleotide targeting protein kinase A, and the epidermal growth factor receptor inhibitor Iressa causes cooperative antitumor and antiangiogenic activity.
2001 Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Fontanini, G; Melisi, Davide; Veneziani, BIANCA MARIA; Zunino, F; Bianco, Ar; Ciardiello, F.
Combined blockade of PKA and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis.
2001 Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Fontanini, G; Cuccato, S; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello, F.
Antitumor activity of combined treatment of human cancer cells with ionizing radiations and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide.
2000 Bianco, C; Bianco, Roberto; Tortora, Giampaolo; Damiano, Vincenzo; Guerrieri, P; Montemaggi, P; Mendelsohn, J; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello,
Oral antisense targeting protein kinase A cooperates with taxol and inhibits tumor growth, angiogenesis and growth factors production.
2000 Tortora, Giampaolo; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello, F.
A novel mdm2 antisense oligonucleotide has antitumor activity and potentiates cytotoxic drugs acting by different mechanisms in human colon cancer.
2000 Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Chen, J; Agrawal, S; Bianco, Ar; Ciardiello, F.
Antiangiogenic and antitumor activity of anti-EGFR C225 monoclonal antibody in combination with Vascular Endothelial Growth Factor antisense oligonucleotide in human GEO colon cancer cells.
2000 Ciardiello, F; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; Caputo, R; Pomatico, G; DE PLACIDO, Sabino; Bianco, Ar; Mendelsohn, J; Tortora, Giampaolo
Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an EGFR-selective tyrosine kinase inhibitor.
2000 Ciardiello, F; Caputo, R; Bianco, Roberto; Damiano, Vincenzo; Pomatico, G; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| The mechanisms of resistance to EGFR inhibitors. | 1.1 Articolo in rivista | 2007 | Bianco, Roberto; Gelardi, Teresa; Damiano, Vincenzo; Tortora, Giampaolo | |
| Combination of biological therapies in non-small cell lung cancer. | 1.1 Articolo in rivista | 2006 | Bianco, Roberto; Damiano, Vincenzo; Tortora, Giampaolo | |
| Novel TLR9 agonist induces EGFR inhibition and synergistic antitumor activity with EGFR inhibitors. | 1.1 Articolo in rivista | 2006 | Damiano, Vincenzo; Caputo, R; Bianco, Roberto; D'Armiento, FRANCESCO PAOLO; Leonardi, Antonio; DE PLACIDO, Sabino; Bianco, Ar; Agrawal, S; Ciardiello, F; Tortora, Giampaolo | |
| A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients. | 1.1 Articolo in rivista | 2005 | De Vita, F; Orditura, M; Matano, E; Bianco, Roberto; Carlomagno, Chiara; Infusino, S; Damiano, Vincenzo; Simeone, E; Diadema, Mr; Lieto, E; Castellano, P; Pepe, S; DE PLACIDO, Sabino; Galizia, G; Di Martino, N; Ciardiello, F; Catalano, G; Bianco, A. R. | |
| Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer. | 1.1 Articolo in rivista | 2005 | Melisi, Davide; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Veneziani, BIANCA MARIA; Bianco, Ar; DE PLACIDO, Sabino; Ciardiello, F; Tortora, Giampaolo | |
| Therapeutic integration of signal transduction targeting agents and conventional anti-cancer treatments. | 1.1 Articolo in rivista | 2004 | Melisi, Davide; Troiani, T; Damiano, Vincenzo; Tortora, Giampaolo; Ciardiello, F. | |
| Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy. | 1.1 Articolo in rivista | 2004 | Ciardiello, F; Bianco, Roberto; Caputo, R; Caputo, R; Damiano, Vincenzo; Troiani, T; Melisi, D; DE VITA, F; DE PLACIDO, Sabino; Bianco, Ar; Tortora, G. | |
| A phase II study of beweekly oxaliplatin plus infusional 5fluorouracil and folinic acid (FOLFOX4) as first-line treatment of advenced gastric cancer patients | 1.5 Abstract in rivista | 2004 | F., De Vita; M., Orditura; Matano, Elide; Bianco, Roberto; Carlomagno, Chiara; S., Infusino; Damiano, Vincenzo; E., Simeone; Mr, Diadema; E., Lieto; P., Castellano; S., Pepe; DE PLACIDO, Sabino; G., Galizia; F., Ciardiello; G., Catalano; Ar, Bianco | |
| Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model. | 1.1 Articolo in rivista | 2004 | Raben, D; Bianco, C; Damiano, Vincenzo; Bianco, Roberto; Melisi, Davide; Mignogna, C; D'Armiento, FRANCESCO PAOLO; Cionini, L; Bianco, Ar; Tortora, Giampaolo; Ciardiello, F; Bunn, P. | |
| Combined targeted inhibition of Bcl-2, Bcl-xL, EGFR and Protein Kinase A Type I causes potent antitumor, apoptotic and antiangiogenic activity | 1.1 Articolo in rivista | 2003 | Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Caputo, R; Troiani, T; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Ar; ZANGEMEISTER WITTKE, U; Ciardiello, F. | |
| Antitumor effects of ZD6474, a small molecule Vascular Endothelial Growth Factor receptor tyrosine kinase inhibitor, with additional activity against Epidermal Growth Factor. | 1.1 Articolo in rivista | 2003 | Ciardiello, F; Caputo, R; Damiano, Vincenzo; Caputo, R; Troiani, T; Vitagliano, D; Carlomagno, F; Veneziani, BIANCA MARIA; Fontanini, G; Bianco, Ar; Tortora, Giampaolo | |
| Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective EGFR-tyrosine kinase inhibitor ZD1839 (‘Iressa’) | 1.1 Articolo in rivista | 2002 | Bianco, C; Tortora, Giampaolo; Bianco, Roberto; Caputo, R; Veneziani, BIANCA MARIA; Caputo, R; Damiano, Vincenzo; Troiani, T; Fontanini, G; Raben, D; Pepe, Stefano; Bianco, Ar | |
| Inhibition of growth factors production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. | 1.1 Articolo in rivista | 2001 | Ciardiello, F; Caputo, R; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; Cuccato, S; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo | |
| Oral administration of a novel taxane, an antisense oligonucleotide targeting protein kinase A, and the epidermal growth factor receptor inhibitor Iressa causes cooperative antitumor and antiangiogenic activity. | 1.1 Articolo in rivista | 2001 | Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Fontanini, G; Melisi, Davide; Veneziani, BIANCA MARIA; Zunino, F; Bianco, Ar; Ciardiello, F. | |
| Combined blockade of PKA and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis. | 1.1 Articolo in rivista | 2001 | Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Fontanini, G; Cuccato, S; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello, F. | |
| Antitumor activity of combined treatment of human cancer cells with ionizing radiations and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide. | 1.1 Articolo in rivista | 2000 | Bianco, C; Bianco, Roberto; Tortora, Giampaolo; Damiano, Vincenzo; Guerrieri, P; Montemaggi, P; Mendelsohn, J; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello, | |
| Oral antisense targeting protein kinase A cooperates with taxol and inhibits tumor growth, angiogenesis and growth factors production. | 1.1 Articolo in rivista | 2000 | Tortora, Giampaolo; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello, F. | |
| A novel mdm2 antisense oligonucleotide has antitumor activity and potentiates cytotoxic drugs acting by different mechanisms in human colon cancer. | 1.1 Articolo in rivista | 2000 | Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Chen, J; Agrawal, S; Bianco, Ar; Ciardiello, F. | |
| Antiangiogenic and antitumor activity of anti-EGFR C225 monoclonal antibody in combination with Vascular Endothelial Growth Factor antisense oligonucleotide in human GEO colon cancer cells. | 1.1 Articolo in rivista | 2000 | Ciardiello, F; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; Caputo, R; Pomatico, G; DE PLACIDO, Sabino; Bianco, Ar; Mendelsohn, J; Tortora, Giampaolo | |
| Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an EGFR-selective tyrosine kinase inhibitor. | 1.1 Articolo in rivista | 2000 | Ciardiello, F; Caputo, R; Bianco, Roberto; Damiano, Vincenzo; Pomatico, G; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile